Tikun Olam USA

Tikun Olam USA is a biopharmaceutical company specializing in the development and commercialization of medical cannabis products based on extensive clinical research. As the American arm of the Israeli pioneer Tikun Olam, the company utilizes a proprietary database of over 20,000 patients to refine its strain-specific treatments. Their product line features clinically-backed strains such as Avidekel, Erez, and Midnight, which target indications including Crohn's disease, chronic pain, and epilepsy. Tikun Olam USA operates a licensing model, partnering with established cultivators and processors to ensure pharmaceutical-grade consistency across multiple US states. The company's mission is to bridge the gap between traditional medicine and cannabis through rigorous scientific validation and standardized delivery methods.